BUZZ-Kodiak Sciences dips after boosted $160 mln equity raise

Reuters12-17 21:39
BUZZ-Kodiak Sciences dips after boosted $160 mln equity raise

** Eye-drug developer Kodiak Sciences' KOD.O shares down 0.6% before the bell at $23.98 after $160 mln follow-on priced

** Palo Alto, California-based biotech late Tues said it sold ~7 mln shares at $23, a 4.7% discount to last sale

** KOD shares closed up nearly 5% on Tues after co late Mon commenced 6 mln share offering

** Co, which has ~53 mln shares outstanding, plans to use net proceeds for working capital and general corp purposes, per the prospectus

** JP Morgan, Jefferies, Evercore and UBS are joint bookrunners

** Through Tues close, KOD shares surged nearly seven-fold over the past six months, putting them up ~143% YTD

** Avg rating among 8 analysts is "buy" and median PT is $24, per LSEG data

(Lance Tupper is a Reuters market analyst. The views expressed are his own)

((lance.tupper@tr.com 1-646-279-6380))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment